Also known as: University of California San Francisco
ARVO named Sangeetha Kandoi and Ellen Konadu Antwi-Adjei as the 2026 recipients of its annual Advocacy Awards. The honors recognize advocacy in eye and vision research and efforts to expand equitable access to care.
Trump administration cuts to U.S. science funding have raised fears of a brain drain, with thousands of grants cancelled and researchers moving abroad. Experts warned the losses could damage biomedical innovation and the economy.
Researchers have developed new immunotherapy approaches including internal immune cell reprogramming and CD40-based therapies showing promising results in early trials. Meanwhile, glioblastoma remains resistant to current immunotherapies due to blood-brain barrier constraints, though advances in antibody engineering offer new potential strategies.
Dr. Vinay Prasad, director of the FDA's Center for Biologics Evaluation and Research, will depart the agency by the end of April to return to an academic role at the University of California San Francisco.
The FDA approved acalabrutinib combined with venetoclax for chronic lymphocytic leukemia and small lymphocytic leukemia based on phase III trial results. Separately, Yale researchers identified CD25 protein complex as a new drug target for aggressive leukemias.
Vie Ventures, a life sciences venture capital firm focused on autoimmune and immune-mediated diseases, announced that Jeff Bluestone, PhD, has been named Managing Director, joining founders Steven St. Peter, MD, and Luke Evnin, PhD.
A study published in JAMA Cardiology found that semaglutide would be cost-effective for secondary cardiovascular disease prevention in U.S. adults with overweight or obesity at an 18% price reduction or at the current cash price of $5,988 annually.
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT07604675 |
Patient Agreement Form and Medication Abortion Knowledge |
COMPLETED | NA |
| NCT07604662 |
Real-Time Acute Kidney Injury Perioperative Prediction Clinical Trial |
NOT_YET_RECRUITING | NA |
| NCT07602374 |
Efficacy of Written Versus Video Patient Education Materials for Postmastectomy Breast Reconstruction |
NOT_YET_RECRUITING | NA |
| NCT07601802 |
Acute Risk Monitoring for Oncology Therapy Regimen |
COMPLETED | |
| NCT07596914 |
Multi-site Feasibility of an Integrated Treatment for the Biology and Experience of Depression: The MULTIBED Study |
NOT_YET_RECRUITING | NA |
| NCT07592533 |
A Single Arm Study of Extracorporeal Shockwave Therapy for Management of Erectile Dysfunction |
RECRUITING | NA |
| NCT07584395 |
Regular Growth Monitoring (RGM) of Young Children in Guinea-Bissau |
NOT_YET_RECRUITING | NA |
| NCT07584369 |
Short-term Effects of Methamphetamine on Residual Latent HIV Disease Study |
NOT_YET_RECRUITING | PHASE4 |
| NCT07582523 |
Out-of-office Monitoring for Rhythms Of Normal Versus Atrial Fibrillation |
ENROLLING_BY_INVITATION | NA |
| NCT07579442 |
Incorporating Narrative Into the Treatment of Youth With Anorexia Nervosa (Virtual) |
RECRUITING | NA |
